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Abstract  
Introduction: In developing countries, factors such as late patient presentation, inaccessible and limited health facilities contribute to the poor 
outcome  in  the  management  of  patients  with  head  and  neck  malignant  tumors.  This  study  presents  the  challenges  faced  by  the 
otorhinolaryngologist in our environment in the management of patients with head and neck malignant tumors. Methods: This is a ten-year 
retrospective chart review of patients with histopathologically confirmed head and neck malignancies in the Jos University Teaching Hospital, Jos, 
Nigeria. Results: Eighty nine patients, with male predominance (gender ratio of 2.7:1) aged between 23 and 78 years had head and neck 
malignancies. Eighty eight (99%) patients had histopathological diagnosis. Most patients were from rural areas and had seen the herbalist prior to 
presentation. Thirty four (38.2%) patients were in the 4th decade of life. Eighteen (20.2%) patients presented within 6 months of onset of illness 
and 71 (79.8%) patients after 6 months with 38/89 patients having cervical lymphadenopathy at presentation. Four (4.5%) patients were able to 
afford CT scan. Twenty eight deaths were recorded. Ten patients were lost to follow-up. Conclusion: The challenges faced in managing patients 
with head and neck malignant tumors in our environment are enormous but surmountable. Therefore urgent efforts should be made by health 
workers and government to ensure a better outcome for these patients.  
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Introduction 
 
The  management  protocol  for  patients  with  head  and  neck  malignant  tumors  involves  a  full  history  of  the  disease  and  clinical  examination 
supplemented by investigations such as computerized tomographic (CT) scan and magnetic resonance imaging (MRI). Further assessment with 
fine needle aspiration biopsy (FNAB) and an examination under anesthesia helps to provide a histological diagnosis enabling the commencement of 
early and proper treatment [1-3].  
  
Both tumor and patient factors affect the final outcome of patients with head and neck malignant tumors. These factors include age of patient, 
stage of tumor at presentation and the presence or absence of concomitant medical conditions.  
  
The interplay of several factors in our environment contributes to the poor outcome in the management of patients with head and neck malignant 
tumors. These factors are late patient presentation, inaccessible and limited health facilities and the delay in the availability of histopathology 
results following biopsies [4].  
  
This study highlights the challenges faced by the otorhinolaryngologist in our environment in the management of patients with head and neck 
malignant tumors and we recommend ways to improving the overall outcome of this disease.  
  
  
Methods 
 
Approval was obtained for this retrospective study from the Ethical Clearance Committee of the Jos University Teaching Hospital.  
  
The medical records of patients with histopathologically confirmed head and neck malignancies presenting to the otorhinolaryngology unit of the 
Jos University Teaching Hospital, Jos, Nigeria over a period of 10 years (July 1998 to June 2008) were analyzed for age, gender, social class of 
patient, time of presentation, nodal stage of disease at presentation, diagnostic protocol and the outcome of treatment. Patients were followed up 
throughout the study period and beyond for treatment outcome.  
  
  
Results 
 
Eighty nine patients with head and neck malignancies aged between 23 years and 78 years were managed. There were 65 (73.0%) males and 24 
(27.0%) females giving a male to female ratio of 2.7:1. Thirty four (38.2%) patients were in the 4
th decade of life (Table 1). Table 2 shows the 
representation of the various types of head and neck malignancies seen during the study period.  
  
Thirty one (34.8%) patients presented with N1 nodal disease, 22 (24.7%) patients with N2a nodal disease and 36 (40.5%) patients with N2b 
nodal disease. The least clinical stage at presentation was a stage 2 disease and the most advanced stage at presentation was stage 4b.  
  
The duration between disease onset and presentation for all the patients ranged from 3 to 18 months with 18 (20.2%) patients presenting within 6 
months of onset of illness and 71 (79.8%) patients after 6 months. Thirty two (36%) patients visited the herbalist in the course of their illness 
before presenting to the hospital.  
  
Thirty eight (42.7%) patients had cervical lymph node enlargement at presentation. Twenty six (68.4%) of these patients were subjected to open 
cervical lymph node biopsy by the general surgeons who were the first contact health personnel in our tertiary health center. The results from the 
pathologists which took a minimum of two weeks were reported as inconclusive and an advice for further evaluation of the patients to search for 
primaries in the head and neck. Twelve (31.6%) patients had FNAB with 9 positive for malignancy. All patients sustained scar following open 
biopsy, 15 (57.7%) had tumor spread.  
  
Four (4.5%) patients were able to afford CT scan and these were of the high income group, 31(34.8%) patients belonged to the middle income 
group and 54 (60.7%) to the low income group. Eighty eight (99%) patients had endoscopic histologic biopsy of their primary tumors under 
general anesthesia and these were referred to a hospital about 200 kilometers away for chemo-radiotherapy because our hospital lacks facilities for 
radiotherapy. Four patients had total laryngectomy on account of laryngeal cancer before being referred for chemo-radiotherapy. One patient with 
nasopharyngeal cancer died before he could have endoscopic biopsy.  
  
A total of 28 (32.6%) deaths were recorded- twenty two (79%) deaths were due to cancer, 5 (17.5%) from co-morbid medical conditions and in 
1(3.5%), the cause of death was unknown. Ten patients were lost to follow-up.  
  
  
Discussion 
 
Malignant tumors of the head and neck constitute one of the 10 most frequent malignancies worldwide with more than 500,000 new cases 
diagnosed annually [5]. They display considerable diverse variation in geographical distribution with varying epidemiological reports from different 
parts of the world for the different sub-sites in the head and neck [6,7]. The variation in incidence by sub-site is mostly related to the relative 
distribution of major risk/etiological factors such as tobacco or bidi smoking, tobacco or betel quid chewing, alcohol consumption, viruses, diet and 
familial risks [7]. The incidences of these diseases are higher in regions of the world where tobacco use and alcohol consumption is high [8]. The 
record of the incidence of head and neck malignancies in Nigeria is scanty [9].  
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Varying factors affect the outcome of this disease worldwide. In our environment, the interplay of several factors contributes to the eventual poor 
outcome in the management of patients with head and neck malignancies. These factors include late patient presentation, inaccessible health 
facilities, limited diagnostic and therapeutic tools, the delay in the availability of histopathology results following biopsies and the practice of 
subjecting patients with head and neck lymphadenopathy to open lymph node biopsy in the face of the afore mentioned [4].  
  
Two major factors contribute to patients presenting late to hospitals in our environment and these are poverty and ignorance [10]. Majority of 
patients in our environment, especially those in the rural areas lack the financial means to access modern health facilities due to high poverty level 
and this is further compounded by harmful traditional beliefs and practices which makes them visit the herbalist for solutions to their health 
problems so that by the time they present to us, their tumors would have reached advanced stages and hence a poor outcome in management. 
This is buttressed by the fact that most of our patients belong to the low income group and therefore could not afford diagnostic facilities like CT 
scan even on presentation. The high income patients who presented to us had CT scan and they benefitted from this radiological diagnosis and are 
still alive following treatment.  
  
Thirty eight (42.7%) of the patients in our series who had cervical lymphadenopathy at presentation were referred to the general surgeons in our 
center and were subjected to open cervical biopsies with attendant complications such as scar formation and tumor spread which was worsened by 
the delay in the availability of histological reports. Fine needle aspiration biopsy is preferable to open biopsy of a cervical lymph node for the 
reasons that there is no tumor spread, no inconvenient scar to distort future surgical intervention, no delay between diagnosis and treatment and 
its simplicity. When a diagnosis of malignancy cannot be made by needle biopsy, then an open biopsy can be done provided it can be followed by 
a frozen section and a concomitant definitive neck dissection if peroperative positive histological diagnosis is obtained [11]. Open cervical lymph 
node biopsy can alter patterns of lymphatic drainage for up to 1 year following surgery [12] and creates a scar which distorts future surgical 
intervention therefore altering the outcome of treatment [11].  
  
Facilities for frozen section are not available in our center and delay in getting histopathology results from the open cervical biopsies and also 
following panendoscopy as seen in our study further compounds our patients’ problems as their tumors and disease process progresses further 
with eventual poor outcome.  
  
There are only 5 functioning radiotherapy centers in Nigeria catering for a population of over 140 million. Our hospital lacks such facilities, which 
means that even when histological diagnosis is established, our patients still have to travel several kilometers to obtain treatment in another 
hospital with facilities for treatment. This also costs money and patients who cannot afford it end up not receiving treatment. We are of the opinion 
that majority of the patients we lost to follow-up fall into this category.  
  
The challenges encountered in managing patients with head and neck malignant tumors in our environment are enormous but surmountable. The 
overall outcome of managing patients with head and neck malignant tumors can be improved upon and we therefore recommend the following: 1) 
Health workers should intensify efforts at educating individuals especially in the rural communities on these diseases specifying the importance of 
early hospital presentation and discouraging harmful traditional practices; 2) All patients with head and neck lymphadenopathy who present to any 
physician for diagnostic examination should undergo formal ENT staging and FNAB to avoid the problems of tumor spread and the reduction in 
consequent prognosis; 3) Even as prioritizing health care needs is a difficult task for developing nations in the face of limited and diminishing 
resources, our governments should wake up to their responsibilities. They have a pivotal role to play in capacity building and the development of 
our health care systems for adequate diagnosis and treatment that would ensure a better prognosis for patients with malignant head and neck 
tumors in our environment.  
  
  
Conclusion 
 
The  challenges  encountered  in  managing  patients  with  head  and  neck  malignant  tumors  in  our  environment  are  surmountable.  Health  care 
providers and government should play committed roles in ensuring a better outcome in the management of these patients.  
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Table 1: Age distribution of patients with histopathologically confirmed head and neck malignancies presenting to 
the otorhinolaryngology unit of the Jos University Teaching Hospital, Jos, Nigeria over a period of 10 years (July 1998 
to June 2008) 
Age (years)  Frequency  Percentage 
21-30  8  8.9 
31-40  34  38.2 
41-50  28  31.5 
51-60  12  13.5 
61-70  4  4.5 
71-80  3  3.4 
Total  89  100 
  
 
 
 
 
 
Table 2: Frequencies of Head and neck cancers seen in a 99 patients with histopathologically confirmed head and neck 
malignancies presenting to  the otorhinolaryngology unit of the Jos University Teaching Hospital, Jos, Nigeria over a 
period of 10 years (July 1998 to June 2008) 
Cancer type  Frequency  Percentage 
Nasopharyngeal    46  51.7 
Oropharyngeal                                6  6.7 
Hypopharyngeal                              2  2.2 
Sino-nasal                                  24  27 
Laryngeal  7  7.9 
Parotid                                             4  4.5 
Total  89  100 
  
 